Alpha‐synuclein pathology in isolated rapid eye movement sleep behaviour disorder: a meta‐analysis
Journal of Sleep Research · 2024-12 · 33 (6)
DOI: 10.1111/jsr.14204 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of Sleep Research, online erschienen am 08.04.2024. Verfasst von Imran H Iftikhar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Pulmonary, Allergy, Critical Care & Sleep Medicine, Emory University School of Medicine, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: REM Sleep Behavior Disorder, alpha-Synuclein. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Accumulating evidence indicates that patients with isolated rapid eye movement sleep behaviour disorder (iRBD), a prodromal stage of synucleinopathies, show abnormal deposition of misfolded alpha‐synuclein (a‐Syn) in peripheral tissues. The clinical utility of testing for a‐Syn in iRBD is unclear. This meta‐analysis focused on the utility of testing for the abnormal a‐Syn phosphorylated at Ser129 (p‐syn) and a‐Syn seeding activity (a‐Syn seed amplification assays [aSyn‐SAA]). Following an electronic database search, 15 studies were included that provided at a minimum data on test positivity in participants with iRBD. Test positivity from cerebrospinal fluid (CSF) was 80% (95% confidence interval [CI] 68–88%, I 2 = 71%) and for skin was 74.8% (95% CI 53.2–88.5%, I 2 = 64%) for aSyn‐SAA and 78.5% (95% CI 70.4–84.9%, I 2 = 14%) for p‐syn. The phenoconversion rate ratio of biopsy‐positive versus biopsy‐negative iRBD was 1.28 (95% CI 0.68–2.41, I 2 = 0%). Skin as a source had a specificity of 99% (95% CI 95–100%, I 2 = 0%; p = 0.01 compared to CSF). As a test, p‐syn, had a specificity of 100% (95% CI 93–100%, I 2 = 0%; p < 0.001) compared to aSyn‐SAA. The odds ratio of a‐Syn test positivity in iRBD versus other RBDs was 112 (95% CI 20–629, I 2 = 0%). These results demonstrate clinically significant test positivity in iRBD and favour skin over CSF as the source of a‐Syn pathological analysis, and p‐syn over aSyn‐SAA as the testing method. Overall, these findings indicate that testing for a‐Syn could help in differentiating iRBD from RBD secondary to other conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Pulmonary, Allergy, Critical Care & Sleep Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
- Atlanta Veterans Affairs Medical Center, Decatur, Georgia, USA.
- Neurology Unit, Department of Medicine, King Saud University, Riyadh, Saudi Arabia.
- Shifa College of Medicine (medical student), Shifa Tameer-e-Millat University, Islamabad, Pakistan.
- Department of Medicine, University Sleep Disorders Center, and Pulmonary Service, King Saud University, Riyadh, Saudi Arabia.
- Strategic Technologies Program of the National Plan for Sciences and Technology and Innovation in the Kingdom of Saudi Arabia, Riyadh, Saudi Arabia.
ORCID-Profile: Imran H Iftikhar, Ahmed S BaHammam
Zitieren
APA
Iftikhar, I. H., AlShimemeri, S., Rabah, H., Rao, S. T., & BaHammam, A. S. (2024). Alpha‐synuclein pathology in isolated rapid eye movement sleep behaviour disorder: a meta‐analysis. Journal of Sleep Research, 33(6). https://doi.org/10.1111/jsr.14204
Vancouver
Iftikhar IH, AlShimemeri S, Rabah H, Rao ST, BaHammam AS. Alpha‐synuclein pathology in isolated rapid eye movement sleep behaviour disorder: a meta‐analysis. Journal of Sleep Research. 2024;33(6). doi:10.1111/jsr.14204
BibTeX
@article{Iftikhar2024,
author = {Iftikhar, Imran H and AlShimemeri, Sohaila and Rabah, Hussein and Rao, Saad Tauheed and BaHammam, Ahmed S},
title = {Alpha‐synuclein pathology in isolated rapid eye movement sleep behaviour disorder: a meta‐analysis},
journal = {Journal of Sleep Research},
year = {2024},
volume = {33},
number = {6},
doi = {10.1111/jsr.14204}
}
EUVIMED